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The thermal inactivation of broad specificity pro-
teases such as thermolysin and subtilisin is initiated by
partial unfolding processes that render the enzyme sus-
ceptible to autolysis. Previous studies have revealed
that a surface-located region in the N-terminal domain
of the thermolysin-like protease produced by Bacillus
stearothermophilus is crucial for thermal stability. In
this region a disulfide bridge between residues 8 and 60
was designed by molecular modelling, and the corre-
sponding single and double cysteine mutants were con-
structed. The disulfide bridge was spontaneously
formed in vivo and resulted in a drastic stabilization of
the enzyme. This stabilization presents one of the very
few examples of successful stabilization of a broad spec-
ificity protease by a designed disulfide bond. We pro-
pose that the success of the present stabilization strat-
egy is the result of the localization and mutation of an
area of the molecule involved in the partial unfolding
processes that determine thermal stability.
Several members of the bacterial genus Bacillus are known
to produce extracellular neutral proteases (1–6) that resemble
thermolysin, the extremely stable protease from Bacillus ther-
moproteolyticus. These so-called thermolysin-like proteases
(TLPs)
1 consist of 300–319 residues and share similar struc-
tural and functional characteristics. The three-dimensional
structures of thermolysin (7, 8) and the TLP produced by Ba-
cillus cereus (9, 10) have been solved by x-ray crystallography.
On the basis of these structures, reasonably accurate models of
other TLPs have been built (11). Naturally occurring TLPs
exhibit large differences in thermal stability (11) and the struc-
tural features causing these differences have been the subject
of several site-directed mutagenesis studies (11, 12).
At elevated temperatures TLPs as well as subtilisins are
irreversibly inactivated as a result of autolysis (13–15). Be-
cause of the broad specificity of TLPs (16), conformational
features rather than sequence characteristics determine the
sites of autolytic attack (17), and it has been shown that the
rate of thermal inactivation is determined by the rate of local
unfolding processes that render the protease susceptible to
autolysis (11–13, 15, 18, 19). Previous studies on autolysis of
broad specificity proteases (13, 15, 17, 20) together with obser-
vations concerning the structural changes during protein un-
folding (21, 22) suggest that the local unfolding processes that
lead to autolysis involve solvent-exposed regions (17, 19, 20).
Accordingly, it has recently been shown that the difference in
stability between TLP of Bacillus stearothermophilus (TLP-ste)
and the more stable thermolysin is determined mainly by
amino acid differences at the surface (12). Furthermore, it
turned out that the important mutations were clustered in a
limited part of the N-terminal domain (especially residues 56–
69) of the protein, illustrating the localized nature of the sta-
bility-determining unfolding processes (11, 12). One mutant
that stabilized TLP-ste rather strongly was T63F (23) (see Fig.
1A). Based on these observations we decided to try to stabilize
TLP-ste by introducing a disulfide bond in this critical area
(preferably close to position 63), the rationale being that, in
principle, a disulfide bond can reduce local mobility and un-
folding more than any other type of mutation.
Disulfide bonds can make considerable contributions to the
stability of proteins (24–26), an effect mainly attributed to the
decrease of conformational chain entropy of the denatured pro-
tein (26–29). Many attempts have been made to increase pro-
tein stability by introduction of novel disulfide bonds (24, 27,
30–39). Some studies turned out to be successful (35–37, 39),
whereas others did not give the expected results (30, 31, 34,
38). Disappointing results have been mainly attributed to side
effects of the individual Xaa 3 Cys mutations (31, 34, 35, 38)
and/or to the introduction of strain resulting from suboptimal
geometry of the disulfide bridge (30, 32).
In the case of industrially important broad specificity pro-
teases such as subtilisin (31, 33, 34) and TLPs (38), most
attempts to stabilize these enzymes by the introduction of
disulfide bridges have been unsuccessful. Only for one engi-
neered disulfide bridge in subtilisin E has a considerable in-
crease in thermal stability been reported (36). However, this
disulfide bridge was not designed de novo but was designed on
the basis of a disulfide bridge encountered in a naturally oc-
curring, more thermostable subtilisin variant.
In the present study we show how TLP-ste can be stabilized
dramatically by introducing a de novo designed disulfide
bridge. Furthermore, we provide an explanation for the lack of
success in earlier attempts to stabilize broad specificity pro-
teases by engineered disulfide bridges.
MATERIALS AND METHODS
Reagents—1,4-Dithio-DL-threitol (DTT) and N-(3-[2-furyl]acryloyl)-
Gly-Leu amide were purchased from Sigma-Aldrich Chemie GmbH
(Deisenhofen, Germany), and urea was from ICN Biomedicals GmbH
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SERVA Feinbiochemica GmbH (Heidelberg, Germany). All other chem-
icals used were of the highest quality commercially available.
Design of Disulfide Mutants—A three-dimensional model of TLP-ste
was built exploiting the sequence homology with thermolysin (7, 8) as
described previously (11). Most model building and structural studies
were done using the program WHAT IF (40). Residues are numbered
throughout this paper according to the sequence of thermolysin (1).
Sites for insertion of disulfide bridges were selected using the pro-
gram SS-BOND (41) as described previously (38). This program uses
the backbone coordinates from the three-dimensional model to select
residue pairs on the basis of the calculated Cb-Cb distances. Subse-
quently, Sg positions with ideal or nearly ideal geometries were gener-
ated for the selected pairs. An energy minimization procedure was used
to select acceptable conformations. Acceptable residue pairs that were
located in the stability limiting region in the N-terminal domain were
visually inspected using the thermolysin crystal structure and the
TLP-ste model. To minimize the risk of modelling errors, the Xaa 3 Cys
mutations were chosen only in regions where thermolysin and TLP-ste
are highly similar. The most promising candidate appeared to be G8C/
N60C. This cysteine pair could be modelled with close to ideal geometry
and is located close to the aforementioned position 63. The two cys-
teines, as well as the individual single mutations, were introduced in a
cysteine-free variant of TLP-ste (C288L-TLP-ste, called wild type
throughout this study) whose stability is nearly identical to that of
unmutated TLP-ste (42).
Plasmids and Strains—Plasmid pGE530
42 contains the gene encod-
ing the C288L variant of TLP-ste, which was used as wild type in this
study. The protease-deficient strain Bacillus subtilis DB117
43 was used
as host for this plasmid, and its variants were obtained by site-directed
mutagenesis. Cells harboring these plasmids were grown at 37 °C in TY
broth containing 5 mg/ml chloramphenicol as antibiotic. The Esche-
richia coli strains WK6mutS and WK6
44 as well as XL-1 Blue MRF9
(Stratagene GmbH, Heidelberg, Germany) and the plasmids pMa (46)
and pBluescript II SK(1) (Stratagene) were used in site-directed mu-
tagenesis procedures.
Site-directed Mutagenesis—The plasmid pGE530 was used as tem-
plate for the construction of the N60C single mutant by site-directed
mutagenesis via polymerase chain reaction (megaprimer method (45)).
Polymerase chain reaction fragments containing the mutation were
cloned into pBluescript II SK(1) (Stratagene), and restriction mapping
was used to screen for mutant clones. The double mutant G8C/N60C
was constructed using the pMa/c system (44, 46) as described previously
(42), by simultaneous annealing of two mutagenic primers. The se-
quence of mutated DNA fragments was verified by dideoxy sequencing
(47) before using the fragments to construct pGE530 variants contain-
ing mutated forms of the TLP-ste gene. The G8C mutant was obtained
by cutting and ligating appropriate fragments of the wild type gene and
the gene encoding the double mutant.
Expression and Purification of Wild Type and Mutant Enzymes—
Wild type and mutant proteins were produced and purified as described
previously (43, 48) using affinity chromatography on Bacitracin-silica.
The enzymes were stored in elution buffer containing 20 mM sodium
acetate, pH 5.3, 5 mM CaCl2, 2.5 M NaCl, 20% (v/v) isopropanol, and
0.03% (w/v) sodium azide.
An alternative purification scheme was applied to samples to be used
for CD measurements. After separation of cells from the fermentation
broth (10 min at 6000 rpm, BECKMAN J2-HC), the supernatant was
concentrated by ultrafiltration (FILTRON ProVario-3-System) using an
8-kDa membrane (Nova series, FILTRON), and proteins were precipi-
tated with ammonium sulfate (85% saturation). The precipitate was
collected by centrifugation (20 min at 20000 rpm, BECKMAN L8–60 M
ultracentrifuge), redissolved in 0.05 M Tris buffer, pH 7.5, 5 mM CaCl2
and dialyzed twice against the same buffer. The concentrated enzyme
was further purified by chromatography on a DEAE-Sephacel (Phar-
macia Biotech Inc.) column equilibrated with 0.05 M Tris buffer, pH 7.5,
5m MCaCl2. The enzyme was recovered in the flow through, and active
fractions were concentrated by ultrafiltration (DIAFLO membrane) and
further purified using gel filtration chromatography (either on Seph-
adex G75, equilibrated with 0.05 M Tris buffer, pH 9.0, 5 mM CaCl2,o r
on HiLoad Superdex75, equilibrated with 0.05 M Tris buffer, pH 7.5, 5
mM CaCl2, both column materials being from Pharmacia Biotech Inc.).
Both purification procedures yielded electrophoretically homogene-
ous enzyme (SDS-PAGE (49)). The specific neutral protease inhibitor
phosphoramidon (50) (final concentration, 1 mM) was added to samples
for SDS-PAGE to prevent autodigestion of the enzyme.
Characterization of Enzymes—Thermal stability was expressed as
T50 being the temperature of incubation at which 50% of the initial
activity of a 0.1 mM solution of purified enzyme in 20 mM sodium acetate,
pH 5.3, 5 mM CaCl2, 0.5% (v/v) isopropanol, 62.5 mM NaCl, 0.03% (w/v)
sodium azide, and 0.01% (v/v) Triton X-100 was retained after 30 min.
Initial and residual enzyme activities were determined using a casein
assay at 37 °C as described previously (51). The assay was calibrated
using a standard wild type enzyme preparation, and an arbitrary unit
for protease activity was defined as the amount of activity required to
increase the absorbance at 275 nm by 1 per minute under the conditions
of the assay (52). The stability of mutant enzymes is given as DT50,
representing the difference in T50 between the wild type and mutant
enzymes. The T50 values reported in this article differ slightly from
previously published values as a result of some modifications of the
assay conditions as used in Ref. 12. 0.01% (v/v) Triton X-100 was
included in the assay mixtures to prevent unspecific binding of the
protease to the surface of the reaction vessels.
The time course of thermal inactivation was followed using the same
conditions as described above. The enzymes were incubated at defined
temperatures, and the aliquots removed after different time intervals
were assayed for activity toward casein at 37 °C.
The kinetic parameter kcat/Km for N-(3-[2-furyl]acryloyl)-Gly-Leu
amide was determined according to the method of Feder (53) using a
buffer containing 10 mM MOPS, pH 7.0,5mMCaCl2, 0.02% (v/v) Triton
X-100, 1% (v/v) isopropanol, and 125 mM NaCl. Activities were derived
from the decrease in absorption at 345 nm, using a De of 317 M
21 cm
21.
The decrease in absorption was recorded at 37 °C, using a thermostat-
ted cuvette in a Perkin-Elmer Lambda 11 spectrophotometer (Perkin-
Elmer Corp.).
CD spectra were recorded using a JASCO J-710 circular dichroism
spectrometer. Measurements were performed at 25 °C using a quartz
cell of 1-mm path length. Samples contained 0.08 mg of enzyme/ml in
0.05 M Tris buffer, pH 9.0, 5 mM CaCl2. Protein concentrations were
determined with the Micro BCA protein assay reagent (Pierce) using
bovine serum albumin as a standard.
Free thiols were determined according to Ellman (54) under dena-
turing conditions (6 M urea); the presence of free thiol groups in the
G8C/N60C mutant was determined without or with previous incubation
with reducing agents (0.2 M DTT). Excess of reducing agent was re-
moved via extensive dialysis. The amount of free sulfhydryl groups was
calculated using an extinction coefficient of 13,600 M
21 cm
21.
SDS-PAGE analysis of purified TLP-ste variants was performed
using a method essentially similar to the method described by Laemmli
(49). The presence of disulfide bonds was analyzed by comparing mo-
bilities during SDS-PAGE of enzyme samples that had been prepared in
the absence or the presence of reducing agent.
RESULTS
Design and Production of the Mutants—Fig. 1 (A and B)
shows the 8–60 disulfide mutant as designed in the three-
dimensional model of TLP-ste. The disulfide bond connects the
N-terminal b-hairpin (residues 1–25) with a region that is
crucial for thermal stability (residues 56–69) (11, 12). Inspec-
tion of the thermolysin crystal structure and the TLP-ste model
indicated that the individual mutations needed for the disul-
fide bond (G8C and N60C) would not lead to significant clashes
or have other negative side effects.
The selected mutants were constructed and could success-
fully be expressed in B. subtilis DB117. Wild type TLP-ste,
G8C, and G8C/N60C mutants were similar with respect to
expression levels and yields of purification. The expression
level was approximately three times lower for the N60C mu-
tant. Wild type and mutant proteins had similar specific activ-
ities toward casein as substrate at 37 °C, pH 7.5 (81.5 6 5.3
units/mg, 82.3 6 5.0 units/mg, 75.0 6 5.2 units/mg, 82.4 6 6.2
units/mg protein for purified wild type, G8C, N60C, and double
mutant enzymes, respectively). The kcat/Km of the double mu-
tant enzyme for the synthetic dipeptide substrate N-(3-[2-furyl]
acryloyl)-Gly-Leu amide (53) was similar to that of the wild
type enzyme (27.8 6 3.5 z 10





Nonreducing SDS-PAGE showed that the double mutant
enzyme migrated slightly faster than the wild type enzyme,
whereas identical mobilities were observed in the presence of
reducing agent (DTT; results not shown). This suggests that
Stabilization by an Engineered Disulfide Bond 11153the expected disulfide bond was formed in vivo in the G8C/
N60C mutant. No free thiol groups could be detected by thiol
titrations (under denaturing conditions) with Ellman’s reagent
(54), confirming the spontaneous formation of the disulfide
bridge in the double mutant. After treatment with excess of
DTT (0.2 M), the number of sulfydryl groups in the double
mutant was determined to be 1.95 6 0.15/molecule.
The CD spectrum of the double mutant was identical to that
of the wild type enzyme (not shown), indicating that the terti-
ary structure had not changed significantly as a result of the
introduced disulfide bond.
Thermal Stability—Purified, electrophoretically homogene-
ous wild type and mutant enzymes were used for determining
T50 as described under “Materials and Methods.” As shown in
Table I, the single mutant enzymes were considerably less
stable than the wild type enzyme (DT50 is 211.0 and 216.2 °C,
for G8C and N60C, respectively). Reducing agents had a sta-
bilizing effect on the single mutant enzymes but only a small
effect on the wild type enzyme. This suggests that the decrease
in thermal stability of the single mutants is at least partly due
to oxidation of the introduced cysteine residue and, possibly,
formation of intermolecular disulfide bonds (55).
Despite the destabilizations observed for the single mutants,
the double mutant displayed a drastic increase in T50 (DT50 5
116.7 °C). DTT reduced the stability of this mutant, but even
at 10 mM DTT the mutant was much more stable than the wild
type (DT50 51 11.8 °C). Thus, it seems that the engineered
disulfide bridge is rather resistant toward reduction. At higher
DTT concentrations (50–100 mM) the stability of the double
mutant was further reduced, but stability measurements at
such high concentrations could not be performed accurately,
because increasing DTT concentrations resulted in consider-
able decrease of the enzymatic activity in wild type and in all
mutant enzymes.
In the temperature range of 80–95 °C for the stable double
mutant enzyme and 55–75 °C for the unstable single mutant
enzymes, the kinetics of thermal inactivation was measured
and compared with those of the wild type TLP-ste. In all cases
the inactivation was irreversible and followed a first order
kinetics. Thermal inactivation of the double mutant coincided
in the usual manner with the disappearance of protein mate-
rial visible in SDS-PAGE gels (Fig. 2). The results (Table II)
confirmed the low stability of the single mutants and the ex-
treme stabilization obtained by introduction of the disulfide
FIG.1 .The engineered disulfide bond in TLP-ste. A, detail of the TLP-ste model containing mutations G8C, N60C, and T63F (side chains
as dotted lines). The side chains shown in bold lines interact with the side chain of residue 63, as described previously (23). B,C - atrace of the
G8C/N60C double mutant of TLP-ste. Crosses indicate bound calcium and zinc ions (the zinc ion is located at the bottom of the active site cleft).
The N and C termini are indicated.
Stabilization by an Engineered Disulfide Bond 11154bond. The half-life of the enzyme at 92.5 °C was increased more
than 120-fold, from less than 0.3 to 36 min. Remarkably, even
the stability of the most stable naturally occurring TLP, ther-
molysin, was exceeded considerably (Table II).
DISCUSSION
In the present study we provide the first example of drastic
stabilization of a broad specificity protease by a de novo de-
signed engineered disulfide bridge. In terms of kinetic stability,
the disulfide containing mutant of TLP-ste is one of the most
stable enzymes ever obtained by protein engineering. The sta-
bility of this designed mutant is comparable with the stability
of a recently published mutant of TLP-ste in which five amino
acids (all in the 1–70 region) had been replaced (12) by the
corresponding residues in a naturally occurring more stable
TLP variant (thermolysin).
Broad specificity proteases, in particular subtilisin, were
among the first enzymes the stability of which was manipu-
lated using protein engineering (31, 33, 34, 36, 38). Attempts to
introduce disulfide bridges were successful in the sense that it
turned out that, indeed, completely rational design of sponta-
neously forming disulfide bridges was possible (31, 33, 35, 36).
However, the stabilizing effects of these mutations were disap-
pointing (30, 31, 34, 38). Taking into account that the rate of
thermal inactivation of broad specificity proteases is deter-
mined by the rate of local unfolding processes preceding autol-
ysis (11–13, 18, 19) we propose that the lack of success of these
engineered disulfide bridges is at least partly due to the fact
that these bridges were introduced in regions of the protease
molecule that do not play a role in stability-determining local
unfolding processes. Designed disulfide bridges have been ex-
tremely successful in cases were the stability measurement
was based on monitoring global (as opposed to local) unfolding
(24, 35). In these cases, the success of the bridge is more
exclusively determined by the success of the design, and much
less (if at all) by the location of the bridge in the molecule.
Unfortunately, the phenomenon of autolysis prevents analysis
of reversible unfolding in TLPs (e.g. Ref. 13). In cases where
stability is determined by autolysis or other irreversible mech-
anisms of inactivation that do not depend on complete unfold-
ing, mutational effects are at least partly determined by the
location of the mutation. Accordingly, the present study shows
that unspecific proteases can be stabilized dramatically by
introduction of disulfide bridges, provided that thorough sta-
bility studies have indicated where the bridge has to be intro-
duced. Only bridges introduced in regions involved in the sta-
bility determining local unfolding processes will lead to
stabilization, and if such a region is found, the resulting stabi-
lization may be enormous.
It may be possible to stabilize TLP-ste even more effectively
if the rate-limiting cleavage sites are known. However, as a
result of the rapid degradation after the first cleavage, it has so
far not been possible to isolate kinetically relevant autolytic
breakdown products of TLP-ste.
2 The present and previous
data (12) on engineering the stability of TLP-ste clearly show
that the stability of this enzyme is determined by a part of the
N-terminal domain (important mutations have been found be-
tween positions 1 and 70). It remains to be elucidated where
the stability determining autolytic cleavages take place and
what extent of local unfolding is needed for those to occur. The
present study shows, however, that highly successful rational
design of stabilizing mutations in TLP-ste is possible on the
basis of the information that is currently available.
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